Renee D. Gala
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Renee D. Gala
Renee D. Gala is recorded as CEO at Jazz Pharmaceuticals plc (JAZZ). The proxy statement of Jazz Pharmaceuticals plc reports total compensation of $19,151,558 for Renee D. Gala in fiscal 2025, including a base salary of $1,003,269. Disclosed compensation is on record for 3 fiscal years. Renee D. Gala has spoken on 1 earnings call across 1 company, most recently for Jazz Pharmaceuticals plc on August 3, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Jazz Pharmaceuticals plc
Other people whose current roles at this company are on record from its filings.
- Bruce Cozadd CEO, Board Member
- Renee Gala CEO, COO, Board Member
- Matthew P. Young CFO
- Philip Johnson CFO
- Renée D. Galá CFO
- Chris Tovey COO
- Renée Galá COO
- Neena M. Patil General Counsel
- Patricia Carr Chief Accounting Officer
- Anne O’Riordan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Jazz Pharmaceuticals plc (JAZZ) | President, CEO and Director | $1,003,269 | $19,151,558 |
| 2024 | Jazz Pharmaceuticals plc (JAZZ) | President, CEO and Director | $824,923 | $6,628,888 |
| 2023 | Jazz Pharmaceuticals plc (JAZZ) | President, CEO and Director | $767,719 | $5,434,388 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.